Koninklijke Philips Other Operating Income or Expenses 2010-2025 | PHG
Koninklijke Philips annual/quarterly other operating income or expenses history and growth rate from 2010 to 2025. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
- Koninklijke Philips other operating income or expenses for the quarter ending March 31, 2025 were $0.012B, a 101.88% decline year-over-year.
- Koninklijke Philips other operating income or expenses for the twelve months ending March 31, 2025 were $0.576B, a 209.32% decline year-over-year.
- Koninklijke Philips annual other operating income or expenses for 2024 were $-0.464B, a 19.53% decline from 2023.
- Koninklijke Philips annual other operating income or expenses for 2023 were $-0.577B, a 3141.74% decline from 2022.
- Koninklijke Philips annual other operating income or expenses for 2022 were $0.019B, a 66.6% decline from 2021.
| Koninklijke Philips Annual Other Operating Income or Expenses (Millions of US $) |
|
|---|---|
| 2024 | $-464 |
| 2023 | $-577 |
| 2022 | $19 |
| 2021 | $57 |
| 2020 | $-57 |
| 2019 | $-37 |
| 2018 | $65 |
| 2017 | $86 |
| 2016 | $30 |
| 2015 | $97 |
| 2014 | $-280 |
| 2013 | $117 |
| 2012 | $-390 |
| 2011 | $0 |
| 2010 | $0 |
| 2009 | $0 |
| Koninklijke Philips Quarterly Other Operating Income or Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | $12 |
| 2024-09-30 | $-10 |
| 2024-06-30 | $577 |
| 2023-06-30 | $-3 |
| 2023-03-31 | $-616 |
| 2022-06-30 | $28 |
| 2021-06-30 | $-48 |
| 2020-06-30 | $110 |
| 2019-06-30 | $6 |
| 2018-06-30 | $43 |
| 2017-06-30 | $-6 |
| 2016-12-31 | $9 |
| 2016-09-30 | $7 |
| 2016-06-30 | $1 |
| 2016-03-31 | $13 |
| 2015-12-31 | $54 |
| 2015-09-30 | $26 |
| 2015-06-30 | $1 |
| 2015-03-31 | $16 |
| 2014-12-31 | $-236 |
| 2014-09-30 | $-60 |
| 2014-06-30 | $10 |
| 2014-03-31 | $5 |
| 2013-12-31 | $9 |
| 2013-09-30 | $15 |
| 2013-06-30 | $69 |
| 2013-03-31 | $24 |
| 2012-12-31 | |
| 2012-09-30 | |
| 2012-06-30 | |
| 2012-03-31 | |
| 2011-12-31 | |
| 2011-09-30 | |
| 2011-06-30 | |
| 2011-03-31 | |
| 2010-12-31 | |
| 2010-09-30 | |
| 2010-06-30 | |
| 2010-03-31 | |
| 2009-12-31 | |
| 2009-09-30 | |
| 2009-06-30 | |
| 2009-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $21.684B | $19.503B |
| Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.788B | 27.51 |
| Boston Scientific (BSX) | United States | $154.602B | 38.70 |
| Stryker (SYK) | United States | $144.385B | 30.19 |
| EssilorLuxottica (ESLOY) | France | $135.514B | 0.00 |
| Medtronic (MDT) | Ireland | $103.771B | 14.71 |
| Haleon (HLN) | United Kingdom | $49.845B | 28.36 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.977B | 0.00 |
| ResMed (RMD) | United States | $35.996B | 27.04 |
| GE HealthCare Technologies (GEHC) | United States | $31.796B | 15.10 |
| Agilent Technologies (A) | United States | $31.270B | 20.66 |
| Terumo (TRUMY) | Japan | $27.864B | 36.19 |
| Insulet (PODD) | United States | $22.590B | 88.67 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.137B | 11.65 |
| Baxter (BAX) | United States | $15.534B | 11.60 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.438B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.181B | 21.51 |
| Lantheus Holdings (LNTH) | United States | $5.172B | 13.05 |
| Prestige Consumer Healthcare (PBH) | United States | $4.201B | 18.77 |
| Perrigo (PRGO) | Ireland | $3.629B | 9.20 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.218B | 23.73 |
| Haemonetics (HAE) | United States | $3.178B | 14.48 |
| Envista Holdings (NVST) | United States | $2.859B | 23.76 |
| GN Store Nord (GNNDY) | Denmark | $2.097B | 17.37 |
| QuidelOrtho (QDEL) | United States | $2.041B | 14.04 |
| LeMaitre Vascular (LMAT) | United States | $1.788B | 39.96 |
| AtriCure (ATRC) | United States | $1.624B | 0.00 |
| Neogen (NEOG) | United States | $1.343B | 17.19 |
| Acuren (TIC) | United States | $1.288B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.206B | 12.25 |
| Green Thumb Industries (GTBIF) | United States | $1.175B | 26.43 |
| Kestra Medical Technologies (KMTS) | United States | $1.145B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.050B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.933B | 11.93 |
| InMode (INMD) | Israel | $0.906B | 9.13 |
| CeriBell (CBLL) | United States | $0.624B | 0.00 |
| Evolus (EOLS) | United States | $0.616B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.584B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.558B | 0.00 |
| Owens & Minor (OMI) | United States | $0.532B | 4.41 |
| Valneva SE (VALN) | France | $0.529B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.496B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.450B | 0.00 |
| Surmodics (SRDX) | United States | $0.417B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.355B | 0.00 |
| SNDL (SNDL) | Canada | $0.344B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.336B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.318B | 11.71 |
| Aurora Cannabis (ACB) | Canada | $0.309B | 54.90 |
| Sanara MedTech (SMTI) | United States | $0.275B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.258B | 21.73 |
| Sanuwave Health (SNWV) | United States | $0.247B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.244B | 0.00 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| ZimVie (ZIMV) | United States | $0.233B | 10.57 |
| Biote (BTMD) | United States | $0.205B | 5.77 |
| Brainsway (BWAY) | Israel | $0.197B | 52.15 |
| OraSure Technologies (OSUR) | United States | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.189B | 0.00 |
| Omeros (OMER) | United States | $0.189B | 0.00 |
| Quanterix (QTRX) | United States | $0.188B | 0.00 |
| Organigram Global (OGI) | Canada | $0.183B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.174B | 14.20 |
| TriSalus Life Sciences (TLSI) | United States | $0.173B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.131B | 16.18 |
| Exagen (XGN) | United States | $0.128B | 0.00 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.117B | 0.00 |
| Agape ATP (ATPC) | $0.112B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Fonar (FONR) | United States | $0.087B | 11.17 |
| Quipt Home Medical (QIPT) | United States | $0.075B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Zynex (ZYXI) | United States | $0.070B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.064B | 0.00 |
| Apyx Medical (APYX) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| United Health Products (UEEC) | United States | $0.051B | 0.00 |
| Modular Medical (MODD) | United States | $0.045B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Safety Shot (SHOT) | United States | $0.028B | 0.00 |
| Nephros (NEPH) | United States | $0.028B | 37.57 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |